OCT 12, 2017 12:00 PM PDT

Live-single-cell phenotypic biomarkers measured from primary biopsy samples: An emerging class of biomarkers toward the development of precision diagnostics and the discovery and development

Speaker

Abstract

The promise of precision and personalized medicine is rooted in accurate, highly sensitive, and specific disease biomarkers. This is particularly true for cancer-a disease characterized by marked tumor heterogeneity and diverse molecular signatures. Although thousands of biomarkers have been described, only a very small number have been successfully translated into clinical use. Undoubtedly, there is need for rapid, quantitative, and more cost effective biomarkers for tumor diagnosis and prognosis, to allow for better risk stratification and aid clinicians in making personalized treatment decisions.


OCT 12, 2017 12:00 PM PDT

Live-single-cell phenotypic biomarkers measured from primary biopsy samples: An emerging class of biomarkers toward the development of precision diagnostics and the discovery and development